Journal entry by Amanda Rice —
Drugs that target these checkpoints (called checkpoint inhibitors) can be used to treat some people with non-small cell lung cancer (NSCLC). Cancer.org
Dad will be receiving durvalumab (generic name - imfinzin) every two weeks for the next year. It will be administered through an IV at the cancer center right in Robbinsdale. He still has a port in his chest, so it is a pretty low key appointment for him. He may administer fatigue, but it won't be anything as severe as the radiation / chemo side effects.
More on durvalumab here and here.
A $25 donation to CaringBridge powers a site like Roger's for two weeks. Will you make a gift to help ensure that this site stays online for them and for you?
Comments Hide comments